New Human Study Shows Vitamin K2 Superior to Vitamin K1

2007/04/16 - Cardiovascular Research Institute Maastricht (CARIM)
WASHINGTON -- April 16, 2007 -- A new study published in the April 15, 2007 (volume 109, number 8) issue of Blood, the official journal of the American Society of Hematology, reveals greater benefits of vitamin K2 over K1 in promoting bone and cardiovascular health.

The four-part human study demonstrated that vitamin K2 as menaquinone-7 (or “MK-7”) was superior to vitamin K1 in several important areas, including better absorption, much longer bioavailability and higher efficacy levels in the body.

“This is the first human study using natural vitamin K2 as a dietary supplement. It shows that vitamin K2 as MK-7 is clearly the most beneficial and potent K-vitamin that one can
take,” said lead researcher Leon Schurgers, Ph.D. “Large scale human studies have shown that eating foods rich in vitamin K2 significantly promotes bone health, reduces risk
of bone injury, and significantly promotes cardiovascular health.”